Sedation Dentistry: An Application of Medical Histories ... · 4. Malamed, SF. (2010) Sedation: a...
Transcript of Sedation Dentistry: An Application of Medical Histories ... · 4. Malamed, SF. (2010) Sedation: a...
Sedation Dentistry: An Application of Medical Histories and Observation Records to Create A Protocol Aimed at Identifying High-Risk Patients
Ma#hewS.Bright1,JamesCur6s,D.M.D.2,Mar6nDurkin,M.D.,M.P.H.3,DavidHicklin,D.M.D.2,CynthiaNichols,D.M.D.,M.S.2
References: 1. Dionne RA. Raise the bar for safe sedation, not barriers for access to care. JADA. 2017;148(3):133-137. 2. “Guidelines for the Use of Sedation and General Anesthesia by Dentists” American Dental Association. 2007. 3. Goodchild JH, Donaldson M. New sedation and general anesthesia guidelines. JADA. 2017;148(3):138-141. 4. Malamed, SF. (2010) Sedation: a guide to patient management. St. Louis, Missouri: Mosby Elsevier.
• Thisstudyaimedtoassesspatientoutcomeswhentreatedwiththesedativemedications,midazolam,fentanyl,diazepam,andmeperidine,inthehopeofidentifyinghigh-riskmarkersthatwillguidepatientselectionforin-of<icesedationprocedures
Objective
• Aseriesoflogisticalregressionmodelspresentingoddsratiosbasedonadichotomizedvariablefor
lengthofrecovery<20min.or>20min.resultedintheselectedmodelthatincludedBMI,Co-
morbidities(>1),Age,andMorphineEquivalentschosenbytheAkaikeInformationCriterion
• Aseriesoflinearregressionmodelsbasedonacontinuousvariableforlengthofrecovery(minutes)
resultedintheselectedmodelthatincludedGender(Male),Co-morbidities(>1),Age,Drug
Combination(Versed),DrugCombination(Other),andMorphineEquivalentsperKilogramchosen
byanadjustedR2valueof(0.1018)
Analysis
• Prospectivestudiesrelatedtotheadministration,effectiveness,andsafetyofparenteraladministeredsedationhave
beencalledforasearlyas1986bytheNationalInstituteofHealthConsensusConferenceonAnesthesiaand
Sedation1
• Since2007,theAmericanDentalAssociationrequiresthefollowingfromdentistspracticingmoderatesedation:2
• Atleast60hoursofdidacticinstructioncoupledwiththesupervisedmanagementof20sedation
patientsviatheintravenousrouteduringthecourse
• BasicLifeSupportTrainingforHealthcareProfessionalsCerti<icationobtainedbythedentist,their
assistants,andanyauxiliarystaff
• AdvancedCardiacLifeSupportCerti<icationobtainedbythedentist
• InOctober2016,Resolution37oftheAmericanDentalAssociationwasapprovedbytheHouseofDelegatesin
whichmorestringentrequirementsweresuggestedforalltypesofsedationprovidedinadentalsettingincluding
CO2endtidalmonitoring3
• ThismonitoringtoolwasalreadyutilizedatthePalmettoHealthUSCDepartmentofDentistry
• Thereisstillaneedforevidencesupportedguidelinesthataccountforvariationsinindividualpatientsaswellas
identi<iedvariablesthatimpactsedationoutcomesthemost
Introduction
• Allprocedureswere:• PerformedatPalmettoHealthUSCMedicalGroup,DepartmentofDentistry• Betweenthedatesof:07/01/2013-06/30/2016• Age≥15yearsattimeofprocedure
• 298procedureswereincludedinthisstudy• Linearregressionmodelsandlogisticalregressionmodelswithoddsratioswerecreatedtoinvestigatetherelationship
betweensedativedrugsanddemographicfactorsonapatient’slengthofrecoveryfollowingmoderatesedation
Materials and Methods
1TheUniversityofSouthCarolina,SouthCarolinaHonorsCollege,Columbia,SC,USA2Palme#oHealthUSCMedicalGroup,DepartmentofDen6stry,Columbia,SC,USA
3PrismaHealthResearchCompliance,Columbia,SC,USA
Table 1
Summary of Linear Regression Analysis for Variables Predicting Length of Recovery (Continuous Variable, Minutes)
Coefficients Estimate Std. Error T-Value Pr(>|T|)
Gender (Male) 1.69478 1.02872 1.647 0.1008
Co-morbidities (>1) 3.97855 0.99248 4.009 <.0001*
Age 0.06519 0.03351 1.945 0.0529!
Drug Combination Fentanyl - Versed -1.70116 1.65944 -1.025 0.3063
Drug Combination Other -4.25424 2.34289 -1.816 0.0707!
Morphine Milligram Equivalents per
Kilogram14.87925 7.95897 1.869 0.0628!
* if p < 0.05● if p < 0.1
Residual Standard Error = 7.021
Degrees of Freedom = 236 Adjusted R2 = 0.1018 P-Value = 2.015e-05
• Moderatesedationfordentalpracticeisasafeandeffectivemodalityforprovidingdental
treatmentinaregulatedandcontrolledenvironment• Quantitativedataanalysiscanguidetheimplementationofpracticeprotocolforpatientselectionandmanagementofmoderatesedationprocedures
Conclusion
Table 2
Summary of Logistical Regression Model for Variables Predicting Length of Recovery (Dichotomized Variable, <20 and >20 Minutes)
Variables Odds Ratio -95% CI +95% CI P Value
BMI 1.033 0.991 1.076 0.127
Co-morbidities (>1) 1.890 1.011 3.533 0.046*
Age 1.023 0.999 1.047 0.057!
MorphineEquivalents
* if p < 0.05● if p < 0.1
1.052 0.984 1.124 0.141
• Althoughneithermodelaloneisofsuf<icientqualitytoexplainthecorrelationbetweenthechosenvariablesandthepatient’slengthofrecovery,whencompared,speci<icvariablesareofsigni<icant
interestandwarrantfurtherstudy• Variablesthataresigni<icantinbothmodelsincludethepatient’sageandnumberofco-morbidites
associatedwiththeiroverallhealth• Themorphineequivalents(associatedwithBMI)apatientreceiveswasfoundtobeanindicatorofextendedlengthsofrecovery
• Thespeci<icdrugcombination,(associatedwithmorphineequivalentsperkilogram),wasalsofoundtobeanindicatorofextendedlengthsofrecoveryinthelinearregressionmodel
Discussion
n=
Figure 1. Scatter plots relating variables of Length of Procedure (min) and Length of Recovery (min). Each data point represents one sedation.
• Fentanyl,althoughmorepotentthanothersedativedrugs,allowsforshorterdurationsandincreasedclinicalcontrol,resultinginamorepredictable,shorterrecoverytime4
• DiazepamandMeperidinerepresentsedativedrugswithlongerdurationsandthereforedecreasedclinicalcontrol,yetarestillviableoptionsformoderatesedation
Drug Combinations